Department of Ophthalmology, Ghent University Hospital, Ghent, Belgium.
Center for Medical Genetics Ghent, Ghent University Hospital, Ghent, Belgium.
Ophthalmic Genet. 2021 Oct;42(5):521-532. doi: 10.1080/13816810.2021.1923041. Epub 2021 May 5.
: Late-onset retinal degeneration (L-ORD) is a rare autosomal dominant retinal dystrophy related to gene variants.: Twenty-six patients (21-81 years) with L-ORD due to c.562C>A p.(Pro188Thr) with a mean follow-up time of 8 years (range 1-37 years) underwent an extensive ophthalmic work-up.: Best-corrected visual acuity (BCVA) and visual fields were maintained up to 50 to 55 years (n = 8), with a gradual decline, but conservation of functional central vision between 55 to 65 years (n = 15), followed by a steep decrease in overall visual function beyond 65 years (n = 9). Classic anterior segment findings in L-ORD of abnormally long, anteriorly inserted lens zonules were absent in most patients (n = 24/26). In contrast, findings of iris transillumination and sphincter pupillae atrophy with poor dilation were novel. Patients presented with three completely different initial fundus phenotypes: adjoining pavingstone-like atrophic patches (type 1) (n = 6/20); tiny yellow-white subretinal dots (type 2) (n = 8/20); or larger yellow, thick, round sub-RPE drusenoid deposits (type 3) (n = 4/20). Two patients had a mixed phenotype. Although different in presentation phenotype, patients eventually all progressed to a common panretinal atrophy with diffuse intraretinal pigment migration beyond the age of 65. Progression pace, and thus visual prognosis, differed depending on presentation phenotype. Specifically, type 2 appears to have a more benign course.: Phenotypic analysis showed three distinct presenting phenotypes with a considerable intrafamilial variability both in age of onset of clinical signs and in disease progression, with a fair visual potential (>20/40) until the seventh decade. L-ORD: Late-onset retinal degeneration; C1QTNF5: complement 1Q tumor necrosis factor 5; OCT: Ocular coherence tomography; BCVA: Best-corrected visual acuity; RPE: Retinal pigment epithelium; ffERG: Full-field electroretinography; IRD: Inherited retinal dystrophy; CNV: Choroidal neovascularization; LAZ: Long anteriorly inserted zonules; AMPK: AMP-activated protein kinase; IOP: Intraocular pressure; cSLO: confocal scanning laser ophthalmoscopy; BAF: Blue light autofluorescence; NIR-AF: Near-infrared autofluorescence; NIR-R: Near-infrared reflectance; RF: Red-free; SD-OCT: Spectral domain ocular coherence tomography; HRR: Hardy-Rand-Rittler pseudo-isochromatic plates; AS: anterior segment; UBM: ultrasound biomicroscopy; PCR: Polymerase chain reaction; SNP: Single nucleotide polymorphism; VEGF: Vascular endothelial growth factor; IZ: Interdigitation zone; EZ: Ellipsoid zone; ELM: External limiting membrane; LP: Light perception; AMD: Age-related macular degeneration; SFD: Sorsby fundus dystrophy.
: 晚发性视网膜变性(L-ORD)是一种罕见的常染色体显性视网膜营养不良,与基因变异有关。: 26 名(21-81 岁)因 c.562C>A p.(Pro188Thr)而患有 L-ORD 的患者,平均随访时间为 8 年(范围 1-37 年),接受了广泛的眼科检查。: 最佳矫正视力(BCVA)和视野在 50 至 55 岁之间保持不变(n=8),之后逐渐下降,但在 55 至 65 岁之间保持功能性中央视力不变(n=15),之后超过 65 岁,整体视力功能急剧下降(n=9)。在大多数患者(n=24/26)中,L-ORD 中异常长的、向前插入的晶状体悬韧带的经典前节发现缺失。相比之下,虹膜透照和瞳孔括约肌萎缩伴扩张不良的发现是新颖的。患者表现出三种完全不同的初始眼底表型:相邻铺路石样萎缩斑块(1 型)(n=6/20);微小的黄白色视网膜下点状(2 型)(n=8/20);或更大的黄色、厚、圆形的 RPE 类脂性沉积(3 型)(n=4/20)。两名患者有混合表型。尽管表现不同,但所有患者最终都进展为普遍的全视网膜萎缩,弥漫性视网膜内色素迁移超过 65 岁。进展速度,因此视力预后,取决于表现型。具体来说,2 型似乎具有更良性的病程。: 表型分析显示,三种不同的首发表型存在相当大的家族内变异性,无论是临床体征的发病年龄还是疾病进展,在 70 岁之前都有相当好的视力潜力(>20/40)。L-ORD:晚发性视网膜变性;C1QTNF5:补体 1Q 肿瘤坏死因子 5;OCT:眼相干断层扫描;BCVA:最佳矫正视力;RPE:视网膜色素上皮;ffERG:全视野视网膜电图;IRD:遗传性视网膜营养不良;CNV:脉络膜新生血管;LAZ:长前插入的悬韧带;AMPK:AMP 激活蛋白激酶;IOP:眼内压;cSLO:共焦扫描激光检眼镜;BAF:蓝光自发荧光;NIR-AF:近红外自发荧光;NIR-R:近红外反射率;RF:红色自由;SD-OCT:光谱域眼相干断层扫描;HRR:Hardy-Rand-Rittler 假同色板;AS:前节;UBM:超声生物显微镜;PCR:聚合酶链反应;SNP:单核苷酸多态性;VEGF:血管内皮生长因子;IZ:相互交织区;EZ:椭圆区;ELM:外部限制膜;LP:光感;AMD:年龄相关性黄斑变性;SFD:Sorsby 眼底营养不良。